A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...
“Hyperthyroidism is often linked to Graves’ disease, another autoimmune condition that overstimulates the thyroid. Thyroid ...
News Medical on MSN10d
Anxiety reduction with antidepressants confirmed, long-term effects uncertainA new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
A study published in The British Journal of Psychiatry has revealed new insights into the connection between joint ...
Perfectionism is often elevated in anxiety disorders. These include generalized anxiety disorder (GAD), social anxiety, panic, and post-traumatic stress disorder (PTSD). The fear of being judged ...
Shares in Mind Medicine (MNMD) are surging, following a shift in market sentiment regarding possible growth and the potential ...
Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...
Stage and screen star Josh Gad has put pen to paper to tell his story. His new memoir, In Gad We Trust, is a heartfelt and ...
Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Mind Medicine (MNMD – Research Report). The associated price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback